Healthcare Nov 28, 2021 04:38 PM (GMT+8) · EqualOcean
Cailian news agency, Nov. 28 - kailaiying announced that in the process of continuously providing contract customized R & D and production (cdmo) services for a small molecule chemical innovative drug of a pharmaceutical company, Jilin kailaiying Pharmaceutical Chemistry Co., Ltd., a wholly-owned subsidiary of the company, recently signed a new batch of supply contracts for related products with customers. The contract amount is equivalent to about 2.72 billion yuan, The new supply contract has come into force after being signed and sealed by both parties.